Stock analysts at William Blair decreased their FY2028 earnings estimates for Ionis Pharmaceuticals in a research report ...

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at ...

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...

Under the agreement, Theratechnologies receives exclusive rights in Canada for olezarsen, which is being evaluated for familial chylomicronemia syndrome and severe hypertriglyceridemia ...